Logo image of OMDA

OMADA HEALTH INC (OMDA) Stock Fundamental Analysis

USA - NASDAQ:OMDA - US68170A1088 - Common Stock

22.08 USD
-0.24 (-1.08%)
Last: 9/30/2025, 1:22:21 PM
Fundamental Rating

3

Taking everything into account, OMDA scores 3 out of 10 in our fundamental rating. OMDA was compared to 101 industry peers in the Health Care Providers & Services industry. OMDA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, OMDA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OMDA had negative earnings in the past year.
OMDA Yearly Net Income VS EBIT VS OCF VS FCFOMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

OMDA has a Return On Assets of -15.56%. This is in the lower half of the industry: OMDA underperforms 79.21% of its industry peers.
OMDA has a Return On Equity of -22.00%. This is in the lower half of the industry: OMDA underperforms 66.34% of its industry peers.
Industry RankSector Rank
ROA -15.56%
ROE -22%
ROIC N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMDA Yearly ROA, ROE, ROICOMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60

1.3 Margins

OMDA's Gross Margin of 60.59% is amongst the best of the industry. OMDA outperforms 82.18% of its industry peers.
The Profit Margin and Operating Margin are not available for OMDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMDA Yearly Profit, Operating, Gross MarginsOMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

OMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OMDA remains at a similar level compared to 1 year ago.
Compared to 1 year ago, OMDA has a worse debt to assets ratio.
OMDA Yearly Shares OutstandingOMDA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
OMDA Yearly Total Debt VS Total AssetsOMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

OMDA has an Altman-Z score of 7.50. This indicates that OMDA is financially healthy and has little risk of bankruptcy at the moment.
OMDA has a better Altman-Z score (7.50) than 91.09% of its industry peers.
OMDA has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
OMDA has a better Debt to Equity ratio (0.14) than 73.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 7.5
ROIC/WACCN/A
WACC8.88%
OMDA Yearly LT Debt VS Equity VS FCFOMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

OMDA has a Current Ratio of 4.68. This indicates that OMDA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of OMDA (4.68) is better than 92.08% of its industry peers.
A Quick Ratio of 4.62 indicates that OMDA has no problem at all paying its short term obligations.
OMDA has a better Quick ratio (4.62) than 93.07% of its industry peers.
Industry RankSector Rank
Current Ratio 4.68
Quick Ratio 4.62
OMDA Yearly Current Assets VS Current LiabilitesOMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.18% over the past year.
The Revenue has grown by 38.29% in the past year. This is a very strong growth!
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 32.87% on average over the next years. This is a very strong growth
OMDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.41% yearly.
EPS Next Y55.94%
EPS Next 2Y38.93%
EPS Next 3Y32.87%
EPS Next 5YN/A
Revenue Next Year43.42%
Revenue Next 2Y31.19%
Revenue Next 3Y27.41%
Revenue Next 5YN/A

3.3 Evolution

OMDA Yearly Revenue VS EstimatesOMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
OMDA Yearly EPS VS EstimatesOMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.2 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OMDA. In the last year negative earnings were reported.
Also next year OMDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OMDA Price Earnings VS Forward Price EarningsOMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMDA Per share dataOMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as OMDA's earnings are expected to grow with 32.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.93%
EPS Next 3Y32.87%

More info and screens

0

5. Dividend

5.1 Amount

OMDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OMADA HEALTH INC

NASDAQ:OMDA (9/30/2025, 1:22:21 PM)

22.08

-0.24 (-1.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)N/A N/A
Inst Owners62.6%
Inst Owner ChangeN/A
Ins Owners6.01%
Ins Owner Change100%
Market Cap1.27B
Analysts81.43
Price Target27.8 (25.91%)
Short Float %3.29%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)N/A
EPS NQ rev (1m)13.62%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.15%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.49
P/FCF N/A
P/OCF N/A
P/B 5.93
P/tB 6.43
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.95
BVpS3.72
TBVpS3.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.56%
ROE -22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.59%
FCFM N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.68
Quick Ratio 4.62
Altman-Z 7.5
F-ScoreN/A
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)69.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y55.94%
EPS Next 2Y38.93%
EPS Next 3Y32.87%
EPS Next 5YN/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year43.42%
Revenue Next 2Y31.19%
Revenue Next 3Y27.41%
Revenue Next 5YN/A
EBIT growth 1Y33.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.57%
EBIT Next 3Y32.72%
EBIT Next 5YN/A
FCF growth 1Y27.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.28%
OCF growth 3YN/A
OCF growth 5YN/A